Inhibitory Activity of Levofloxacin against MDR Staphylococcus aureus and Pseudomonas aeruginosa Clinical Isolates

Lisa Nathalie, Lindawati Alimsardjono, Isnaeni Isnaeni

= http://dx.doi.org/10.20473/jfiki.v6i12019.25-31
Abstract views = 254 times | downloads = 220 times

Abstract


Introduction: Staphylococcus  aureus  and  Pseudomonas  aeruginosa  are the most dangerous  and important species among  their genus.  These  bacteria  are often  resistant  to  many  classes  of antimicrobial  agents;  which  make difficulties in selecting appropriate drug to treat infections. Multidrug-resistance occurs readily in hospitals for which antimicrobials  agents  were   used  widely. Objective: The  aims  of  this  study  was  to  determine  minimum  inhibitory concentration  (MIC) and  minimum bacterial  concentration  (MBC) of levofloxacin  against 22 multidrug  resistant- clinical (MDR) strains of Staphylococcus aureus and Pseudomonas aeruginosa isolated from patients pus and urine in hospital. Methods: Determination of the MIC was performed by macro-dilution broth assay as recommended by Clinical and Laboratory Standards Institute (CLSI), while the MBC was determined one-step further after the MIC determination. Results: It was found that MIC of the levofloxacin were (0.3 ± 0.0) - >0.5 µg/mL and (0.2 ± 0.1) - (1.0 ±0.0)µg/mL against S. aureus from pus and urine, respectively.  In addition, higher MICs were yielded against P. aeruginosa, (1.0 ± 0.0) - >8.0 µg/mL and (0.7 ± 0.3) - (3.0 ± 1.2) µg/mL for pus and urine isolates respectively. Similar to MICs, the MBCs against P. aeruginosa were higher than S. aureus, (0.6 ± 0.0) - > 4.0 µg/mL and (0.3 ± 0.0) - >8.0 µg/mL isolated from pus and urine respectively, (2.0 ± 0.6) - > 8.0 µg/mL and (3.0 ± 1.2) - >7.0 µg/mL against P. aeruginosa from pus and urine respectively. Conclusion: The levofloxacin was still susceptible as bacteriostatic against isolates from both body fluids, but not bactericidal towards all isolates.

Keywords


levofloxacin, MDR, Pseudomonas aeruginosa, Staphylococcus aureus

Full Text:

PDF

References


Bambeke, F. V., Gllupeczynski, Y., Plésiat, P., Pechère, J. C. & Tulkens, P. M. (2003). Antibiotic Efflux Pumps in Procaryotic Cells: Occurrence, Impact on Resistance and Strategies for the Future of Antimicrobial Therapy. Journal of Antimicrobial Chemotherapy; 51; 1055-1065.

Brooks, G. F., Butel, J. S. & Morse, S. A. (2001). Jawetz, Melnick and Adelberg’s Medical Microbiology. 22th ed. Boston: Appleton & Lange.

Clinical and Laboratory Standards Institute. (2006). Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically - Seventh Edition; Approved standard M7-A7. Wayne, PA: CLSI.

Clinical and Laboratory Standards Institute. (2006). Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. Wayne, PA: CLSI.

Cunha, B. A. (2001). Effective Antibiotic-Resistance Control Strategies. Lancet; 3537; 1307-1308.

Drago, L., De Vecchi, E., Mombelli, B., Nicola, L., Valli, M. & Gismondo, M. R. (2001). Activity of Levofloxacin and Ciprofloxacin against Urinary pathogens. Journal of Antimicrobial Chemotherapy; 48; 37-45.

Evans, M. E. & Titlow, W. B. (1998). Levofloxacin Selects Fluoroquinolone-resistant Methicillin-

Resistant Staphylococcus aureus Less Frequently than Ciprofloxacin. Journal of Antimicrobial Chemotherapy; 41; 285–288.

Forbes, B. A., Sahm, D. F. & Weissefeld, A. S. (2002). Bailey and Scott’s Diagnostic of Microbiology, 11th ed. St. Louis: Mosby-Year Book, Inc.

Gade, N. D., Oasi, M. S. (2013). Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?. Journal of Laboratory Physicians; 5; 109–112.

Gilbert, D. N., Kohlhepp, S. J., Slama, K. A., Grunkemeier, G., Lewis, G., Dworkin, R. J., Slaughter, S .E. & Leggett, J. E. (2001). Phenotypic Resistance of Staphylococcus aureus, Selected Enterobacteriaceae, and Pseudomonas aeruginosa after Single and Multiple In Vitro Exposures to Ciprofloxacin, Levofloxacin, and Trovafloxacin. Antimicrobial Agents and Chemotherapy; 45; 883–892.

Muller-Serieys, C., Decré, D., Benoit, C., Bigot, C., Maubert, B., Carbon, C. (1999). Levofloxacin: Serum Bactericidal Activity against Methicillin- Resistant Staphylococcus aureus isolates. Journal of Antimicrobial Chemotherapy; 43; 67-70.

Heritage, J., Wilcox, M. & Sandoe, J. (2001). Antimicrobial Resistance Potential. Lancet; 358; 1099-1100.

Janssen-Ortho, Inc. 2005. Levaquin by Jansen-Otrho. http://www.orthomcneil.com/.../assets/common/company/pi/levaquin.pdf;jsessionid=CWW2VR14AOBGWCQPCCEDC0YKB2IIWNSC. Accessed: 25 Juli 2006.

Jorgensen, J. A. & Turnidge, J. D. (2003). Susceptibility Test Methods: Dilution and Disk Diffusion Methods. USA: WMC Brown Publishers.

Kiska, D. L. & Gilligan, P. H. (2003). Manual of Clinical Microbiology (8th ed). Washington, DC: ASM Press,.

Koneman, E. W., Allen, S. D., Janda, W. M., Schreckenberger, P. C. & Winn, Jr., W. C. (1997). Color Atlas and Textbook of Diagnostic Microbiology (5th ed). St. Louis: Mosby, Inc.

MacDougall, C., Harpe, S. E., Powell, J. P., Johnson, C. K., Edmond, M. B. & Polk, R. E. (2005). Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone use. Emerging Infectious Diseases; 11; 1197-1204.

Mitscher, L. A. (2005). Bacterial Topoisomerase Inhibitors: Quinolone and Pyridine Antibacterial Agents. Chemical Reviews; 105; 559-592.

Mizunaga, S., Kamiyama, T., Fukuda, Y., Takahata, M. & Mitsuyama, J. (2005). Influence of Inoculum Size of Staphylococcus aureus and Pseudomonas aeruginosa on in Vitro Activities and in Vivo Efficacy of Fluoroquinolones and Carbapenems. Journal of Antimicrobial Chemotherapy; 56; 91-96.

Montanari, M. P., Mingoia, M., Marchetti, F. & Varaldo, P. E. (1999). In Vitro Activity of Levofloxacin against Gram Positive Bacteria. Chemotherapy; 45; 411-417.

Muramatsu, H., Horii, T., Takeshita, A., Hashimoto, H. & Maekawa, M. (2005). Characterization of Fluoroquinolone and Carbapenem Susceptibilities in Clinical Isolates of Levofloxacin-resistant Pseudomonas aeruginosa. Chemother; 51; 70-75.

Nester, E. W., Roberts, C. E., McCarthy, B. J. & Pearsall, N. N. (1973). Molecules, Microbes, and Man. New York: Holt-Reinhart Winston.

Ostle, B. & Mensing, R. W. (1975). Statistics in Research (3rd ed). Iowa: The Iowa State University Press.

Steel, R. G. D. & Torrie, J. H. (1981). Principles and Procedures of Statistics: A Biometrical Approach (2nd ed). Auckland: McGraw-Hill Inc.

Yao, J. D. C. & Moellering, J. R. (2003). Manual of Clinical Microbiology (8th ed). Washington, DC: ASM Press.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA

View JFIKI Stats

                

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License